A randomized, double-blind, parallel-group, monotherapy study to compare the safety and efficacy of two doses of topiramate in the treatment of newly diagnosed or recurrent epilepsy.
Phase of Trial: Phase III
Latest Information Update: 12 Jan 2010
At a glance
- Drugs Topiramate (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- 12 Jan 2010 Actual patient number (750) added as reported by ClinicalTrials.gov.
- 06 Nov 2005 New trial record.